In May, the FDA cleared the first blood-based diagnostic test for Alzheimer's disease, the Lumipulse G pTau 217/β-Amyloid ...

The nanoparticles act as tiny engineers of cellular behavior, the researchers explain, orchestrating repair at the molecular ...

There are many risk factors for hypertension, the medical term for high blood pressure, including genetics and unhealthy ...

A leading GP advises individuals over 40 to prioritize four key blood tests for proactive health management. These tests, ...

Boost blood flow naturally and improve artery health with 6 simple tips, including diet, exercise, stress management, and ...

A groundbreaking study reveals how obesity may drive Alzheimer’s disease through tiny messengers called extracellular vesicles released from fat tissue.

The blood-based biomarker test measures Tau protein phosphorylated at threonine 181 in human plasma (pTau181).

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.

ST. PAUL, Minn., Oct. 6 (UPI) --Spanish and Chinese scientists said Monday they have used specifically tailored nanoparticles ...